84 related articles for article (PubMed ID: 35210352)
1. Bedtime versus morning use of antihypertensives for cardiovascular risk reduction (BedMed): protocol for a prospective, randomised, open-label, blinded end-point pragmatic trial.
Garrison SR; Kolber MR; Allan GM; Bakal J; Green L; Singer A; Trueman DR; McAlister FA; Padwal RS; Hill MD; Manns B; McGrail K; O'Neill B; Greiver M; Froentjes LS; Manca DP; Mangin D; Wong ST; MacLean C; Kirkwood JE; McCracken R; McCormack JP; Norris C; Korownyk T
BMJ Open; 2022 Feb; 12(2):e059711. PubMed ID: 35210352
[TBL] [Abstract][Full Text] [Related]
2. Pragmatic randomised clinical trial of proton versus photon therapy for patients with non-metastatic breast cancer: the Radiotherapy Comparative Effectiveness (RadComp) Consortium trial protocol.
Bekelman JE; Lu H; Pugh S; Baker K; Berg CD; Berrington de González A; Braunstein LZ; Bosch W; Chauhan C; Ellenberg S; Fang LC; Freedman GM; Hahn EA; Haffty BG; Khan AJ; Jimenez RB; Kesslering C; Ky B; Lee C; Lu HM; Mishra MV; Mullins CD; Mutter RW; Nagda S; Pankuch M; Powell SN; Prior FW; Schupak K; Taghian AG; Wilkinson JB; MacDonald SM; Cahlon O;
BMJ Open; 2019 Oct; 9(10):e025556. PubMed ID: 31619413
[TBL] [Abstract][Full Text] [Related]
3. Effect of timed dosing of usual antihypertensives according to patient chronotype on cardiovascular outcomes: the Chronotype sub-study cohort of the Treatment in Morning versus Evening (TIME) study.
Pigazzani F; Dyar KA; Morant SV; Vetter C; Rogers A; Flynn RWV; Rorie DA; Mackenzie IS; Cappuccio FP; Manfredini R; MacDonald TM
EClinicalMedicine; 2024 Jun; 72():102633. PubMed ID: 38774676
[TBL] [Abstract][Full Text] [Related]
4. Effects of Message Framing and Time Discounting on Health Communication for Optimum Cardiovascular Disease and Stroke Prevention (EMT-OCSP): a protocol for a pragmatic, multicentre, observer-blinded, 12-month randomised controlled study.
Zhou M; Guo J; Chen N; Ma M; Dong S; Li Y; Fang J; Zhang Y; Zhang Y; Bao J; Hong Y; Lu Y; Qin M; Yin L; Yang X; He Q; Ding X; Chen L; Wang Z; Mi S; Chen S; Zhu C; Zhou D; He L
BMJ Open; 2021 Mar; 11(3):e043450. PubMed ID: 33762233
[TBL] [Abstract][Full Text] [Related]
5. Rationale and design of the CV-PREVITAL study: an Italian multiple cohort randomised controlled trial investigating innovative digital strategies in primary cardiovascular prevention.
Baldassarre D; Iacoviello L; Baetta R; Roncaglioni MC; Condorelli G; Remuzzi G; Gensini G; Frati L; Ricciardi W; Conaldi PG; Uccelli A; Blandini F; Bosari S; Scambia G; Fini M; Di Malta A; Amato M; Veglia F; Bonomi A; Klersy C; Colazzo F; Pengo M; Gorini F; Auteri L; Ferrante G; Baviera M; Ambrosio G; Catapano A; Gialluisi A; Malavazos AE; Castelvecchio S; Corsi-Romanelli MM; Cardani R; La Rovere MT; Agnese V; Pane B; Prati D; Spinardi L; Liuzzo G; Arbustini E; Volterrani M; Visconti M; Werba JP; Genovese S; Bilo G; Invitti C; Di Blasio A; Lombardi C; Faini A; Rosa D; Ojeda-Fernández L; Foresta A; De Curtis A; Di Castelnuovo A; Scalvini S; Pierobon A; Gorini A; Valenti L; Luzi L; Racca A; Bandi M; Tremoli E; Menicanti L; Parati G; Pompilio G;
BMJ Open; 2023 Jul; 13(7):e072040. PubMed ID: 37451717
[TBL] [Abstract][Full Text] [Related]
6. Northern Shanghai Study II: systematic assessment and management of early organ damage and its role in preventing and reducing cardiovascular risk-protocol of a prospective study.
Hou J; Li M; Han J; Yu S; Jia X; Sun F; Zhang Y
BMJ Open; 2023 Dec; 13(12):e073423. PubMed ID: 38159946
[TBL] [Abstract][Full Text] [Related]
7. Hospitalisation due to acute cardiovascular conditions: is screening for recreational drug use justified?
Choudry FA; Jones DA; Archbold RA
Heart; 2023 Oct; 109(21):1582-1583. PubMed ID: 37582634
[No Abstract] [Full Text] [Related]
8. Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial.
Mackenzie IS; Rogers A; Poulter NR; Williams B; Brown MJ; Webb DJ; Ford I; Rorie DA; Guthrie G; Grieve JWK; Pigazzani F; Rothwell PM; Young R; McConnachie A; Struthers AD; Lang CC; MacDonald TM;
Lancet; 2022 Oct; 400(10361):1417-1425. PubMed ID: 36240838
[TBL] [Abstract][Full Text] [Related]
9. Bedtime dosing of antihypertensive medications: systematic review and consensus statement: International Society of Hypertension position paper endorsed by World Hypertension League and European Society of Hypertension.
Stergiou G; Brunström M; MacDonald T; Kyriakoulis KG; Bursztyn M; Khan N; Bakris G; Kollias A; Menti A; Muntner P; Orias M; Poulter N; Shimbo D; Williams B; Adeoye AM; Damasceno A; Korostovtseva L; Li Y; Muxfeldt E; Zhang Y; Mancia G; Kreutz R; Tomaszewski M
J Hypertens; 2022 Oct; 40(10):1847-1858. PubMed ID: 35983870
[TBL] [Abstract][Full Text] [Related]
10. Nighttime administration of antihypertensive medication: a review of chronotherapy in hypertension.
Kim HJ; Jo SH
Korean J Intern Med; 2024 Mar; 39(2):205-214. PubMed ID: 37967524
[TBL] [Abstract][Full Text] [Related]
11. Non-Dipping Blood Pressure or Nocturnal Hypertension: Does One Matter More?
Tang A; Yang E; Ebinger JE
Curr Hypertens Rep; 2024 Jan; 26(1):21-30. PubMed ID: 37955827
[TBL] [Abstract][Full Text] [Related]
12. Pressure Building Against the Clock: The Impact of Circadian Misalignment on Blood Pressure.
Shafer BM; Kogan SA; McHill AW
Curr Hypertens Rep; 2024 Jan; 26(1):31-42. PubMed ID: 37837518
[TBL] [Abstract][Full Text] [Related]
13. Statement on chronotherapy for the treatment of hypertension: consensus document from the Korean society of hypertension.
Park S; Ihm SH; Cho IJ; Kim DH; Park JH; Chung WB; Choi S; Lee HY; Kim HC; Sohn IS; Lee EM; Kim JH; Kim KI; Cho EJ; Sung KC; Shin J; Pyun WB
Clin Hypertens; 2023 Sep; 29(1):25. PubMed ID: 37653547
[TBL] [Abstract][Full Text] [Related]
14. Bedtime versus morning use of antihypertensives in frail continuing care residents (BedMed-Frail): protocol for a prospective, randomised, open-label, blinded end-point pragmatic trial.
Garrison SR; Youngson E; Perry DA; Campbell FN; Kolber MR; Korownyk C; Allan GM; Green L; Bakal J
BMJ Open; 2023 Aug; 13(8):e074777. PubMed ID: 37527898
[TBL] [Abstract][Full Text] [Related]
15. Tolerability of bedtime diuretics: a prospective cohort analysis.
Garrison SR; Kelmer M; Korownyk T; Kolber MR; Allan GM; Bakal J; Singer A; Katz A; Mcalister F; Padwal RS; Lewanczuk R; Hill MD; McGrail K; O'Neill B; Greiver M; Manca DP; Mangin D; Wong ST; Kirkwood JEM; McCormack JP; Yeung JMS; Green L
BMJ Open; 2023 Jun; 13(6):e068188. PubMed ID: 37280022
[TBL] [Abstract][Full Text] [Related]
16. Top studies of 2022 relevant to primary care: From the PEER team.
Perry D; Moe SS; Thomas B; Lindblad AJ; Kirkwood J; Falk J; Potter J; Paige A; Allan GM
Can Fam Physician; 2023 May; 69(5):325-329. PubMed ID: 37172982
[TBL] [Abstract][Full Text] [Related]
17. Improper administration: Silent culprit of drug therapy problems.
Vitic J; Yakiwchuk E; Crawley A
Can Fam Physician; 2023 Feb; 69(2):107-112. PubMed ID: 36813520
[No Abstract] [Full Text] [Related]
18. [Not Available].
Vitic J; Yakiwchuk E; Crawley A
Can Fam Physician; 2023 Feb; 69(2):e38-e44. PubMed ID: 36813507
[No Abstract] [Full Text] [Related]
19. Blood pressure in heart failure management and prevention.
Maeda D; Dotare T; Matsue Y; Teramoto K; Sunayama T; Tromp J; Minamino T
Hypertens Res; 2023 Apr; 46(4):817-833. PubMed ID: 36604473
[TBL] [Abstract][Full Text] [Related]
20. Toward Precision Medicine: Circadian Rhythm of Blood Pressure and Chronotherapy for Hypertension - 2021 NHLBI Workshop Report.
Gumz ML; Shimbo D; Abdalla M; Balijepalli RC; Benedict C; Chen Y; Earnest DJ; Gamble KL; Garrison SR; Gong MC; Hogenesch JB; Hong Y; Ivy JR; Joe B; Laposky AD; Liang M; MacLaughlin EJ; Martino TA; Pollock DM; Redline S; Rogers A; Dan Rudic R; Schernhammer ES; Stergiou GS; St-Onge MP; Wang X; Wright J; Oh YS
Hypertension; 2023 Mar; 80(3):503-522. PubMed ID: 36448463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
